NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) | Biotech Hunter

Enrollment

892

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

April 26, 2018

Study Completion Date

April 26, 2018

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

INSULIN GLARGINE

"Pharmaceutical form: solution~Route of administration: subcutaneous injection"

DRUG

metformin

"Pharmaceutical form: table or capsule~Route of administration: oral administration"

DRUG

acarbose

"Pharmaceutical form: table or capsule~Route of administration: oral administration"

Trial Locations (1)

China